Legal & General Group’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$703K Sell
18,664
-2,396
-11% -$78.3K ﹤0.01% 2263
2025
Q4
$634K Buy
21,060
+3,269
+18% +$92.5K ﹤0.01% 2349
2025
Q3
$467K Buy
17,791
+2,896
+19% +$69K ﹤0.01% 2467
2025
Q2
$317K Buy
14,895
+14,104
+1,783% +$318K ﹤0.01% 2553
2025
Q1
$16.9K Hold
791
﹤0.01% 3004
2024
Q4
$16K Buy
+791
New +$16.3K ﹤0.01% 3107

Other funds holding GRDN

Legal & General Group's GRDN Position: Q1 2026 in Review

Legal & General Group reduced its Guardian Pharmacy Services (GRDN) stake by 11% in Q1 2026, selling an estimated $78.3K and leaving 18,664 shares worth $703K. The position accounts for ﹤0.01% of the portfolio, ranked #2263.

Legal & General Group first reported a position in GRDN in Q4 2024 and has held it in 6 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Legal & General Group held 18,664 shares of Guardian Pharmacy Services worth $703K as of Q1 2026.
  • Legal & General Group sold 2,396 Guardian Pharmacy Services shares in Q1 2026, an estimated $78.3K.
  • Guardian Pharmacy Services made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2263 holding.
  • Legal & General Group first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 6 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.